RNS Number : 0664V
Renishaw PLC
13 August 2025
 

Renishaw plc

Board Change

Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, announces the following Board change.

The Company is pleased to announce the appointment of Camille Deer as a Non-Executive Director, with effect from 1 September 2025. Camille is granddaughter of John Deer, co-founder of Renishaw plc. Camille brings experience in intellectual property, innovation pipeline and risk management from her other appointments in areas outside of Renishaw's core business interests. Camille holds a MA and MPhil in History from the University of Cambridge.

Commenting on the appointment, Sir David Grant, Interim Non-Executive Chair, said: "Camille is an excellent addition to the strength of our Board having already contributed to enrich discussion during her tenure as an Observer on the Board. I am confident that her appointment will prove to be invaluable in helping to guide the strategic direction of the business whilst demonstrating the continued commitment of the founding families to the future of Renishaw."

In addition to the above change, the Company is continuing its search for a permanent Non-Executive Chair and an additional Independent Non-Executive Director to join the Board.

There are no disclosures required in respect of Camille Deer's appointment under UK Listing Rule 6.4.8R.

 

Kasim Hussain
Group General Counsel & Company Secretary

13 August 2025

 

Renishaw plc

 

Registered office:

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number:

01106260, England and Wales

Telephone:

+44 (0)1453 524524

Website:

www.renishaw.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPTMRTMTBBBAA